Drug Repositioning Market Size, Share, Trends & Forecast

The drug repositioning Market is gaining importance as pharmaceutical companies seek more efficient approaches to drug development. WiseGuyReports estimates the market at USD 13.5 billion in 2024, rising to USD 14.3 billion in 2025 and USD 25 billion by 2035, representing a 5.8% CAGR.

A major attraction of drug repositioning is its potential to improve research efficiency by identifying new applications for existing medicines. Pharmaceutical companies can use established scientific and clinical knowledge as a foundation for exploring additional therapeutic opportunities, supporting efforts to reduce development costs and timelines.

Artificial intelligence and bioinformatics are becoming important technologies within this process. Advanced analytics and machine-learning approaches can help researchers examine large datasets, identify relationships between drugs and disease pathways, and prioritize potential repositioning opportunities. The report identifies AI-driven discovery as one of the market's key opportunities.

Real-world data is another emerging market trend. Researchers are increasingly examining observational and clinical datasets to identify potential new indications and understand how medicines perform across different populations. This is contributing to a more data-driven approach to drug repositioning.

The market is also benefiting from collaboration between pharmaceutical companies, biotechnology firms, academic institutions, and contract research organizations. As personalized medicine and advanced analytics continue to develop, drug repositioning is expected to remain an important strategy for expanding pharmaceutical pipelines and addressing unmet healthcare needs.

Read More
Lukoon https://lukoon.com